- Reframe Daily
- Archive
- Page 2
Past Issues
Reframe Daily: One-shot antibiotic rivals IVs for staph, brain vessel fixed before birth, Lesser Known Polio Story
A single dose worked as well as IV drugs in a JAMA trial, and doctors treated a risky fetal brain issue before delivery. Plus: a self-guiding intubation robot, a scar-reducing skin test, and timed meals helping Fragile X (in mice).
Reframe Daily: New pill, new probiotic, and proton therapy all show big health gains
Fresh studies out today: a diabetes pill, a gut probiotic, and proton radiation bring strong results in trials; an obesity drug helps those with a rare gene issue; and DNA screening finds newborn diseases sooner.
Reframe Daily: One-shot syphilis treatment, safer clot care, and new insulin-making cells
1 dose penicillin matched 3 for early syphilis; reduced-dose apixaban protected cancer patients; sotatercept improved lung-artery hypertension; lab-grown islets restored insulin; and immune-stealth donor cells lived without daily anti-rejection meds.
Reframe Daily: Tonsil surgery lowers kids’ blood pressure; gene-silencing shot helps weak nerves in mice
Plus: first step of the gluten attack in celiac disease; an RNA switch grows new blood vessels and restores leg blood flow in mice; low-dose statin slows aneurysms in a Marfan model and a CT sign may track risk.
Reframe Daily: Baby RSV nose vaccine, stroke thinking boost + mindfulness vs embodiment
Today’s roundup: infant RSV nasal vaccine shows promise; a precision pill helps a rare blood cancer; cardio rehab after stroke improves thinking; new microspheres seal lungs in tests; and simple salt/urea shifts make T cells fight BK virus better.
Reframe Daily: rectal-cancer trial adds 2 immune drugs; salt water OK in brain surgery; 3D placenta MRI + Stop "Fixing" Yourself
Doctors saw promise with two immune drugs before rectal-cancer surgery, surgeons got brain relaxation with common salt water, a new MRI makes a 3D map of placenta blood flow, a PET/CT tracer helps spot tiny pituitary tumors in Cushing’s disease, and tuning T-cell fuel changed their attack on viruses and lymphoma in the lab.